Skip to content
Kerala Ayurveda logo

Kerala Ayurveda

530163 BSE
₹146.80 up 2.95 (2.05%)
Market Cap
₹191 Cr

Kerala Ayurveda (KERALAYUR) share price was ₹143.85 at the 28 Oct 2026 close; market capitalisation ₹187 Cr; sector Healthcare. The share price fell 66.4% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 16.0% year on year to ₹33.19 Cr and net profit was −₹8.08 Cr, against ₹2.03 Cr a year earlier (compared with Jun 2025). Promoters held 35.61% of Kerala Ayurveda in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 30/100 (Poor) as of 28 Oct 2026.

Close 28 Oct 2026 ₹143.85 −289.65 −66.82% 1Y

Key Fundamentals

MicrocapPharmaceuticals & BiotechnologyHealthcare
Market Cap
₹191 Cr
EBITDA
−₹17.75 Cr
Return on Equity
-108.29%
Debt to Equity
7.82
Book Value
₹17.50
EPS (TTM)
−₹21.06
52W High
₹439.50
52W Low
₹130.00

Price-based figures as of 29 Oct 2026, 10:30 IST · EPS basis: Consolidated · TTM

Peer Comparison

Healthcare › Pharmaceuticals

Sun Pharma
₹1,764.0034.994,23,243 Cr5.060.91%13.79%17.94%61,848 Cr12,117 Cr
Divis Laboratories
₹9,667.5087.742,56,642 Cr15.310.32%15.32%18.96%11,682 Cr2,925 Cr
Torrent Pharmaceuticals
₹4,590.6072.071,74,612 Cr9.500.82%12.16%9.06%17,058 Cr2,156 Cr
Laurus Labs
₹2,194.10108.401,18,550 Cr22.370.09%16.38%19.67%7,323 Cr1,090 Cr
Zydus Life Science
₹1,183.9026.341,18,094 Cr4.360.09%16.99%19.24%28,515 Cr4,593 Cr
Dr Reddys Laboratories
₹1,338.7034.671,11,739 Cr2.880.61%10.87%13.94%34,247 Cr3,184 Cr
Cipla
₹1,365.7032.721,10,329 Cr3.120.96%11.21%14.88%28,589 Cr3,356 Cr
Kerala Ayurveda (this company)
₹146.80—191 Cr8.390.00%-108.29%-19.98%141 Cr-26 Cr
Median 8 companies₹1,564.8534.991,18,322 Cr6.730.47%12.98%16.41%22,787 Cr3,055 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

30 Poor
Overall score

Data confidence 91/100

Category scores

Quality Poor 15
Returns, margins, earnings quality 22% weight
Valuation Poor 20
Cheap vs sector & own history 24% weight
Growth Average 54
Sales & profit trajectory 9% weight
Financial Health Poor 13
Solvency, leverage, coverage 9% weight
Momentum Poor 12
Trend strength, vol-adjusted 12% weight
Ownership Strong 66
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Debtor days have improved from 51.1 to 38.4 days.

Weaknesses

5
  • Stock is trading at 17.1 times its book value
  • Company has low interest coverage ratio.
  • Promoter holding is low: 35.6%
  • Company has a low return on equity of -85.2% over last 3 years.
  • Promoter holding has decreased over last 3 years: -25.9%

Technical Indicators

Oscillators

Bearish

Bearish
2
Neutral
6
Bullish
1

Overall

Bearish

Bearish
10
Neutral
6
Bullish
3

Moving Averages

Bearish

Bearish
8
Neutral
0
Bullish
2

Growth Rate

Revenue Growth
7.32% lower than 3Y

change over 1 year

Net Income Growth
16.57%

change over 1 year

Cash Flow Change
603%

change over 1 year

EBITDA Margin Change
370%

change over 1 year Operating margin -11.54% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
23.78
25.03
26.32
32.03
27.47
30.41
31.13
31.32
28.61
34.84
32.96
34.74
33.19
Expenses
22.25
24.49
25.31
26.58
26.67
24.88
32.32
41.46
32.8
39.79
34.47
41.84
37.02
Operating Profit
1.53
0.54
1.01
5.45
0.8
5.53
-1.19
-10.14
-4.19
-4.95
-1.51
-7.1
-3.83
OPM %
6.43%
2.16%
3.84%
17.02%
2.91%
18.18%
-3.82%
-32.38%
-14.65%
-14.21%
-4.58%
-20.44%
-11.54%
Other Income
0.16
0.77
0.23
-0.86
0.22
0.64
0.23
0.73
9.47
1.7
1.13
1.91
0.26
Interest
1.51
0.65
0.61
3.26
0.46
0.72
0.43
2.48
0.82
2.58
2.84
1.1
2.79
Depreciation
0.33
0.32
0.34
1.15
0.36
1.98
0.72
1.92
1.65
0.99
1.15
1.69
1.87
PBT
-0.15
0.34
0.29
0.18
0.2
3.47
-2.11
-13.81
2.81
-6.82
-4.37
-7.98
-8.23
Tax %
106.67%
100%
368.97%
-194.44%
-125%
-4.9%
27.96%
11.3%
27.76%
-6.74%
5.26%
-7.39%
-1.82%
Net Profit
-0.3
0
-0.79
0.53
0.46
3.65
-2.7
-15.38
2.03
-6.36
-4.6
-7.39
-8.08
EPS (₹)
-0.34
-0.12
-0.9
0.22
0.27
2.84
-2.4
-12.92
1.65
-5.26
-3.69
-5.97
-6.14
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
39
46
50
59
59
77
62
80
93
108
126
131
136
Expenses
33
38
43
51
54
69
61
71
91
100
131
149
153
Operating Profit
6
8
7
8
5
7
1
10
3
9
-5
-18
-17
OPM %
15%
16%
14%
14%
9%
10%
1.4%
12%
2.8%
8%
-4%
-14%
-13%
Other Income
0
0
0
0
1
0
0
1
3
0
2
14
5
Interest
2
2
1
2
3
2
6
7
5
6
4
7
9
Depreciation
1
2
2
2
1
1
1
1
1
2
5
5
6
PBT
3
4
4
4
3
5
-7
3
-1
1
-12
-16
-27
Tax %
21%
33%
22%
31%
19%
11%
-28%
15%
-23%
185%
14%
0%
—
Net Profit
3
3
3
3
3
4
-5
2
0
-1
-14
-16
-26
EPS (₹)
2.24
2.56
2.9
2.66
2.31
3.69
-4.59
2.24
-0.85
-0.47
-11.6
-12.74
-21.06
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
11
11
11
11
11
11
11
11
11
12
12
13
Reserves
-19
-17
-4
-3
-7
-3
-7
-4
-5
7
-3
-2
Borrowings
70
69
56
75
62
64
77
70
72
76
71
86
Other Liabilities
11
11
17
20
27
31
34
34
37
38
49
41
Total Liabilities
73
73
81
103
92
103
114
110
115
133
129
138
Fixed Assets
33
34
34
32
33
33
33
44
46
41
47
50
CWIP
0
0
6
11
12
14
14
4
7
7
9
8
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
40
39
41
59
47
56
68
62
61
85
73
81
Total Assets
73
73
81
103
92
103
114
110
115
133
129
138
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0
6
4
-10
12
5
7
0
10
-1
5
-24
Investing
0
-3
-3
-3
-3
-4
-1
-2
-7
0
-15
-5
Financing
2
-2
0
17
-12
1
6
-13
-2
20
-9
32
Net Cash Flow
2
0
1
4
-2
2
12
-16
0
18
-19
3
Free Cash Flow
0
2
3
-16
10
2
6
-3
4
-2
-8
-30
CFO/OP
8
73
62
-120
251
71
885
-5
390
1
-138
136
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
35
33
35
34
43
51
61
61
51
59
56
38
Inventory Days
287
227
319
338
311
313
268
254
227
205
208
200
Days Payable
150
100
112
125
117
162
149
168
137
114
93
129
Cash Conversion Cycle
172
160
242
247
236
202
179
147
141
149
171
109
Working Capital Days
-131
-103
-213
-63
-24
-19
-99
-118
-81
-172
-147
-162
ROCE %
8%
9%
9%
9%
6%
9%
0%
11%
2%
8%
-9%
-10%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Kerala Ayurveda insights

66 extracted metrics + investor summaries across FY06–FY27.

Shareholding Pattern

DIIs0.04%Public41.80%Others22.55%Promot.35.61%As ofSep 2026
20.35% of promoter holding pledged as of 14 Oct 2026

Documents

Frequently Asked Questions about Kerala Ayurveda

What does Kerala Ayurveda Ltd do?
Incorporated in 1945, Kerala Ayurveda Ltd is engaged In Ayurvedlc services and products[1]
Where is Kerala Ayurveda Ltd (KERALAYUR) listed?
Kerala Ayurveda Ltd trades under code 530163 on the BSE.
Which sector does Kerala Ayurveda Ltd belong to?
Kerala Ayurveda Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Kerala Ayurveda Ltd?
Kerala Ayurveda Ltd has a market capitalisation of ₹190.75 Cr as of 29 Oct 2026, which places it in the Small Cap band.
What is the 52-week high and low of Kerala Ayurveda Ltd?
Over the last 52 weeks Kerala Ayurveda Ltd has traded between ₹130 and ₹439.5 as of 29 Oct 2026.
What is the Return on Equity (ROE) of Kerala Ayurveda Ltd?
Kerala Ayurveda Ltd reported a return on equity of -108.29%. Its debt-to-equity ratio is 7.82.

Company Information

Incorporated in 1945, Kerala Ayurveda Ltd is engaged In Ayurvedlc services and products[1]

Website keralaayurveda.biz
Face Value ₹ 10
Shares Outstanding 1,29,93,991

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/530163.md for Kerala Ayurveda Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Pharma stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month